Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis

NCT07235644 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

184

Enrollment

OTHER

Sponsor class

Conditions

MS (Multiple Sclerosis)
Multiple Sclerosis (MS) - Relapsing-remitting
Multiple Sclerosis (Relapsing Remitting)

Sponsor

Uppsala University